Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10844	Companies
235476	Keywords
164409	Articles
126177	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 05/27/2025 at 14:30, 1 year 2 months ago

Formycon and Fresenius Kabi announce the commercial launch of FYB202/Otulfi™, an approved ustekinumab biosimilar in Canada
Formycon and Fresenius Kabi announce commercial launch of FYB202/Otulfi ustekinumab biosimilar in Canada, expanding treatment options for chronic autoimmune diseases

Canada Formycon Fresenius Kabi Ustekinumab Biosimilar FYB202/Otulfi
BRIEF

published on 05/19/2025 at 15:05, 1 year 2 months ago

Formycon et Fresenius Kabi obtiennent l'approbation d'interchangeabilité de la FDA pour FYB202/Otulfi®

Approbation De La FDA Formycon Fresenius Kabi Biosimilaires Otulfi®
BRIEF

published on 05/19/2025 at 15:05, 1 year 2 months ago

Formycon and Fresenius Kabi Achieve FDA Interchangeability Approval for FYB202/Otulfi®

FDA Approval Biosimilars Formycon Fresenius Kabi Otulfi®
PRESS RELEASE

published on 05/19/2025 at 15:00, 1 year 2 months ago

Formycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for interchangeability of FYB202/Otulfi (ustekinumab-aauz) with Stelara, enhancing patient access to treatment options for inflammatory diseases in the US

FDA Approval Formycon Fresenius Kabi Biologics Interchangeability
BRIEF

published on 05/12/2025 at 06:35, 1 year 3 months ago

Formycon Achieves Key Milestones in Q1 2025 Amid Challenging Conditions

Strategic Partnerships Financial Guidance Formycon Q1 2025 Biosimilar Approvals FYB202 Launch
BRIEF

published on 05/12/2025 at 06:35, 1 year 3 months ago

Formycon franchit des étapes clés au premier trimestre 2025 dans des conditions difficiles

Partenariats Stratégiques Orientation Financière Formycon T1 2025 Approbations De Biosimilaires Lancement Du FYB202
PRESS RELEASE

published on 05/12/2025 at 06:30, 1 year 3 months ago

Formycon reports strong operational performance and financial results for first quarter of 2025
Formycon AG reports strong operational performance and financial results for the first quarter of 2025. Market approvals, revenue growth, and strategic partnerships discussed

Financial Results Operational Performance Formycon AG Biosimilars Market Approvals
BRIEF

published on 05/07/2025 at 09:42, 1 year 3 months ago

Formycon Announces Q1 2025 Results Conference and Investor Conferences

Investor Conferences Formycon AG Management Board Financial Outlook Q1 2025 Results
BRIEF

published on 05/07/2025 at 09:42, 1 year 3 months ago

Formycon annonce sa conférence sur les résultats du premier trimestre 2025 et ses conférences avec les investisseurs

Conseil D'administration Formycon AG Conférences D'investisseurs Perspectives Financières Résultats Du Premier Trimestre 2025
PRESS RELEASE

published on 05/07/2025 at 09:37, 1 year 3 months ago

Formycon invites to conference call on the results of the first quarter of 2025 and announces participation in international investor conferences
Formycon AG to discuss Q1 2025 results in a conference call and participate in investor conferences. Details and webcast link available. Biosimilar development focus

Conference Call Investor Conferences Formycon AG Biosimilars Q1 2025 Results

Accesswire

Published on 08/17/2026 at 22:30, 1 hour 55 minutes ago

Matador Technologies Amends Convertible Note Facility to Expand At the Market Capacity and Commit a Fixed Share of Proceeds to Bitcoin
Published on 08/17/2026 at 21:00, 3 hours 25 minutes ago

Taranis Announces New Critical Minerals By-Product Findings at the Thor and Ajax Mines
Published on 08/17/2026 at 15:00, 9 hours 25 minutes ago

Norsemont Appoints Ariel Tepperman to Its Board
Published on 08/17/2026 at 14:30, 9 hours 55 minutes ago

Alset AI Completes Sale of 9.9% Interest in Lyken AI Computing to FingerMotion
Published on 08/17/2026 at 14:00, 10 hours 25 minutes ago

FaZe Esports, a GameSquare Company, Wins Rainbow Six Championship at 2026 Esports World Cup

View all ACCESSWIRE

EQS Group

Published on 08/17/2026 at 22:30, 1 hour 55 minutes ago

PLAY HAS ARRIVED IN GERMANY
Published on 08/17/2026 at 19:00, 5 hours 25 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 10 AOUT 2026 au 14 AOUT 2026
Published on 08/17/2026 at 18:50, 5 hours 35 minutes ago

Holding(s) in Company
Published on 08/17/2026 at 17:50, 6 hours 35 minutes ago

EvoNext Holdings SA confirms advanced discussions on a reverse merger with Ascend Sport Technology AG
Published on 08/17/2026 at 17:47, 6 hours 38 minutes ago

Key Figures 15.08.2026

Les Echos

Published on 08/17/2026 at 19:45, 4 hours 40 minutes ago

Aéroports de Paris S.A - July 2026 traffic figures
Published on 08/17/2026 at 19:45, 4 hours 40 minutes ago

Aéroports de Paris S.A - Trafic du mois de juillet 2026
Published on 08/17/2026 at 17:45, 6 hours 40 minutes ago

Weekly share buyback
Published on 08/17/2026 at 17:45, 6 hours 40 minutes ago

Déclaration hebdomadaire de rachat d'actions
Published on 08/17/2026 at 17:40, 6 hours 45 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 10 au 14 août 2026 dans le cadre du programme de rachat d’actions.

View all LES ECHOS COMFI WIRE